Pancreatic cancer has a grim prognosis. It is usually detected after the disease has spread, and chemotherapy tends to do little to slow the cancer’s growth. Even with treatment, most patients live only about six months after they are diagnosed with the disease.
Researchers in Professor David Tuveson’s laboratory at Cold Spring Harbor Laboratory (CSHL) think it’s possible to do better with a different type of treatment. Part of the problem, they say, is that cancer cells in the pancreas are protected by the dense matrix that surrounds them. The matrix is a mixture of extracellular components and noncancerous cells known as the stroma. All solid tumors contain stroma. In pancreatic cancers, this fibrous material is particularly abundant, making up nearly 90 percent of a tumor’s mass. This stroma impedes anticancer drugs’ from getting to their targets. Additionally, stromal cells secrete factors that actually help the tumors grow.
Overcoming the stroma’s protective influence has been challenging, but new leads from Tuveson’s team, as reported on October 26, 2018 in the journal Cancer Discovery, point to a promising strategy. In fact, the new findings suggest that drugs which target the right cellular pathways can do more than just thwart tumor-supporting cells in the stroma. They may recruit them into the anticancer fight.
A key element of the stroma is a type of cell called a fibroblast. Fibroblasts manufacture the stroma’s connective tissue. They also generate factors that promote cancer cell growth and prevent the immune system from attacking the cancerous cells. Last year Tuveson’s team discovered that the stroma of pancreatic tumors contains at least two types of fibroblasts. One type show features known to support tumor growth, the other type appear to have the opposite effect.
The good news is that the fibroblasts’ identities are not fixed. With the right cues, tumor-promoting fibroblasts can become tumor-restrictors.
“These cells can convert into one another, depending on the cues they get from the microenvironment and from the cancer cells,” explains Giulia Biffi, a postdoctoral researcher in Tuveson’s lab who led the new study. “This is potentially useful because, in theory, you can shift the tumor-promoting cells to tumor-restraining, rather than just depleting the tumor-promoting cells.”
In this new report, Biffi and her colleagues have identified specific molecular signals released by cancer cells that determine fibroblasts’ character within pancreatic tumors. They have discovered that one such molecule, IL-1, drives fibroblasts to take on a tumor-promoting identity. They have also shown how another molecule, TGF-beta, overrides that signal and keeps fibroblasts in a potentially anticancer state even when IL-1 is present.
The researchers are now exploring what happens to pancreatic tumors when they manipulate IL-1 and TGF-beta signaling and convert tumor-promoting fibroblasts to a more beneficial state. They will also investigate what happens when they target these pathways in combination with chemotherapy or cancer immunotherapies. Ultimately, Biffi says, patients may benefit most from a combination of therapies that target both the cancer cells and parts of the microenvironment that support their growth.
Learn more: Turning cells against pancreatic cancer
The Latest on: Pancreatic cancer
via Google News
The Latest on: Pancreatic cancer
- Pancreatic Cancer - Epidemiology Forecast to 2029on December 4, 2020 at 2:38 am
Reportlinker.com announces the release of the report "Pancreatic Cancer - Epidemiology Forecast to 2029" - Pancreatic cancer occurs when cells in the pancreas develop mutations in their DNA and grow ...
- AB Science announces that confirmatory Phase 3 study AB12005 with masitinib in first line pancreatic cancer with pain was successfulon December 4, 2020 at 1:51 am
AB Science announces that confirmatory Phase 3 study AB12005 with masitinibin first line pancreatic cancer with pain was successful and ...
- 'Magic' Morristown Man, Known By Many, Faces Pancreatic Canceron December 3, 2020 at 8:26 am
Hogie seemingly knows everyone in North Jersey, friends say. Here's how to help as he battles the disease that took his mother.
- Pancreatic cancer survivor wants to raise more awareness for the diseaseon December 1, 2020 at 1:39 pm
"The months of not knowing were stressful. They were stressful on me; they were on my family," said Matt Wilson, who was diagnosed with the disease.
- ‘Girlfriends’ Star Keesha Sharp on Losing Her Mother to Pancreatic Canceron December 1, 2020 at 12:36 pm
Four summers ago, Keesha Sharp found out that her mother had been diagnosed with pancreatic cancer — the third leading cause of cancer-related deaths in America. Sadly, her mom died in ...
- Curiosity and Creativity Fuel Advancements in Pancreatic Cancer Researchon November 30, 2020 at 10:54 pm
From cancer to COVID to computer technology, innovation often begins as a spark of creativity lit by a researcher’s curiosity. Whether viewing existing research through a different lens or bringing a ...
- Pancreatic cancer month - join the fight | Houghtaling and Downeyon November 24, 2020 at 3:46 am
By supporting research, staying vigilant about our own health and risk factors, and making our families and friends aware of this deadly disease, we will help drive the search for hope and a cure." ...
- November marks Pancreatic Cancer Awareness Monthon November 23, 2020 at 11:07 am
November is Pancreatic Cancer Awareness Month. Pancreatic cancer is extremely hard to detect and is the third leading cause of cancer-related deaths in the United States. Julie Fleshman, the president ...
- Pancreatic Cancer Market Research Based on COVID 19 and Analysis on Techniques and Applications Report 2020-2027on November 23, 2020 at 1:40 am
The Global Pancreatic Cancer Market is expected to exceed more than US$ 13 billion by 2024. Browse Full Report: Pancreatic cancer is origins by the unrestrained boom of cells within the pancreas.
via Bing News